Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q2 2010
Highlights from the Q1 2010 review of medical device and in vitro diagnostics/research dealmaking: With most of the funding in the form of venture rounds, medical device financing totaled $548 million in the second quarter, a 10% drop from Q1. Device acquisitions picked up, with 18 transactions completed for an aggregate $4.4 billion. Including GenMark's IPO, the first done in the sector since November 2007, in vitro diagnostic/research financing more than doubled Q1's dollar volume, reaching $364 million in the second quarter. The four IVD/Research acquisitions done in Q2 totalled $226 million.
In this issue, we present another installment of our quarterly
review of medical device, in vitro diagnostics, and
research/analytical dealmaking – for the second quarter of
2010. Our data come from Elsevier's Strategic
Transactions.
Amanda Micklus and
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
